Johns Hopkins Medicine

Alzheimer's Disease Research Center

Treatment of Agitation in Dementia

Principal Investigator: Constantine Lyketsos, M.D., M.H.S.

The goal of this study is to determine if treating dementia patients with a medication that is used to treat depression and anxiety (Escitalopram), in combination with a psychosocial intervention, will reduce symptoms of agitation. Participants in the study will be given either the active drug or a placebo (i.e., a sugar pill) for 9 weeks.

For more information contact Mersania Jn Pierre at 410-550-9022 or e-mail